Interaction Effects of Age and Contingency Management Treatments in Cocaine-Dependent Outpatients

Experimental and Clinical Psychopharmacology

Volumn 19, Issue 2, 2011, Pages 173-181

  Weiss, Lindsay M ^a   Petry, Nancy M ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Age differences; Cocaine; Contingency management; Substance abuse treatment

Indexed keywords

COCAINE;

ADDICTION SEVERITY INDEX; ADULT; AGE DISTRIBUTION; ARTICLE; BRIEF SYMPTOM INVENTORY; COCAINE DEPENDENCE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OUTPATIENT; PSYCHOLOGIC ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; COCAINE-RELATED DISORDERS; FEMALE; HUMANS; MALE; OUTPATIENTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79954473670     PISSN: 10641297     EISSN: 19362293     Source Type: Journal    
DOI: 10.1037/a0023031     Document Type: Article

References (45)

1. Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Author, Washington, DC. 4th ed.
2. Blow F.C., Walton M.A., Chermack S.T., Mudd S.A., Brower K.J. Older adult treatment outcome following elder-specific inpatient alcoholism treatment. Journal of Substance Abuse Treatment 2000, 19:67-75.
3. Bucholz K.K., Hesselbrock V.M., Shayka J.J., Nurnberger J.I., Schuckit M.A., Schmidt I., Reich T. Reliability of individual diagnostic criterion items for psychoactive substance dependence and the impact on diagnosis. Journal of Studies on Alcohol 1995, 56:500-505.
4. Colliver J.D., Compton W.M., Gfroerer J.C., Condon T. Projecting drug use among aging baby boomers in 2020. Annals of Epidemiology 2006, 16:257-265.
5. Derogatis L.R. Brief Symptom Inventory (BSI): Administration, scoring and procedure manual 1993, National Computer Systems, Minneapolis, MN.
6. DeRubeis R.J., Crits-Cristoph P. Empirically supported individual and group psychological treatments for adult mental disorders. Journal of Consulting and Clinical Psychology 1998, 66:37-52.
7. Dutra L., Stathopoulou G., Basden S.L., Leyro T.M., Powers M.B., Otto M.W. A meta-analytic review of psychosocial interventions for substance use disorders. The American Journal of Psychiatry 2008, 165:179-187.
8. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version 1996, American Psychiatric Press, Washington, DC.
9. Frishman W.H., Del Vecchio A., Sanal S., Ismail A. Cardiovascular manifestations of substance abuse: Pt. 1. Cocaine. Heart Disease 2003, 5:187-201.
10. Frishman W.H., Del Vecchio A., Sanal S., Ismail A. Cardiovascular manifestations of substance abuse: Pt. 2. Alcohol, amphetamines, heroin, cannabis, and caffeine. Heart Disease 2003, 5:253-271.
11. Gfroerer J.C., Epstein J.F. Marijuana initiates and their impact on future drug abuse treatment need. Drug and Alcohol Dependence 1999, 54:229-237.
12. Gfroerer J., Penne M., Pemberton M., Folsom R. Substance abuse treatment need among older adults in 2020: The impact of the aging baby-boom cohort. Drug and Alcohol Dependence 2003, 69:127-135.
13. Grella C.E., Hser Y.I., Joshi V., Anglin M.D. Patient histories, retention, and outcome models for younger and older adults in DATOS. Drug and Alcohol Dependence 1999, 57:151-166.
14. Han B., Gfroerer J.C., Colliver J.D., Penne M.A. Substance use disorder among older adults in the United States in 2020. Addiction 2009, 104:88-96.
15. Higgins S.T., Badger G.J., Budney A.J. Initial abstinence and success in achieving longer-term cocaine abstinence. Experimental and Clinical Psychopharmacology 2000, 8:377-386.
16. Lofwall M.R., Brooner R.K., Bigelow G.E., Kindbom K., Strain E.C. Characteristics of older opioid maintenance patients. Journal of Substance Abuse Treatment 2005, 28:265-272.
17. Lofwall M.R., Schuster A., Strain E.C. Changing profile of abused substances by older persons entering treatment. Journal of Nervous and Mental Disease 2008, 196:898-905.
18. Lumley T., Diehr P., Emerson S., Chen L. The importance of the normality assumption in large public health data sets. Annual Review of Public Health 2002, 23:151-169.
19. Lussier J.P., Heil S.H., Mongeon J.A., Badger G.J., Higgins S.T. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006, 101:192-203.
20. Maglione M., Chao B., Anglin M.D. Correlates of outpatient drug treatment drop-out among methamphetamine users. Journal of Psychoactive Drugs 2000, 32:221-228.
21. McKellar J., Kelly J., Harris A., Moos R. Pretreatment and during treatment risk factors for dropout among patients with substance use disorders. Addictive Behaviors 2006, 31:450-460.
22. McLellan A.T., Luborsky L., Cacciola J.S., Griffin J.E. New data from the Addiction Severity Index: Reliability and validity in three centers. Journal of Nervous and Mental Disease 1985, 163:412-423.
23. Moos R.H., Mertens J.R., Brennan P.L. Patterns of diagnosis and treatment among late-middle-aged and older substance abuse patients. Journal of Studies on Alcohol 1993, 54:479-487.
24. Peirce J.M., Petry N.M., Roll J.M., Kolodner K., Krasnansky J., Stabile P.Q., Stitzer M.L. Correlates of stimulant treatment outcome across treatment modalities. American Journal of Drug and Alcohol Abuse 2009, 35:48-53.
25. Petry N.M., Alessi S.M. Prize-based contingency management is efficacious in cocaine abusers with and without recent gambling problems. Journal of Substance Abuse Treatment 2010, 39:282-288.
26. Petry N.M., Alessi S.M., Carroll K.M., Hanson T., MacKinnon S., Rounsaville B., Sierra S. Contingency management treatments: Reinforcing abstinence versus adherence with goal-related activities. Journal of Consulting and Clinical Psychology 2006, 74:592-601.
27. Petry N.M., Alessi S.M., Tedford J., Austin M., Tardif M. Vouchers versus prizes: Contingency management treatment of substance abusers in community settings. Journal of Consulting and Clinical Psychology 2005, 73:1005-1014.
28. Petry N.M., Kolodner K.B., Li R., Peirce J.M., Roll J.M., Stitzer M.L., Hamilton J.A. Prize-based contingency management does not increase gambling: Results of the National Drug Abuse Treatment Clinical Trials Network multi-site study. Drug and Alcohol Dependence 2006, 83:269-273.
29. Petry N.M., Peirce J.M., Stitzer M.L., Blaine J., Roll J.M., Cohen A., Li R. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: A National Drug Abuse Treatment Clinical Trials Network study. Archives of General Psychiatry 2005, 62:1148-1156.
30. Petry N.M., Tedford J., Austin M., Nich C., Carroll K.M., Rounsaville B.J. Prize reinforcement contingency management for treatment of cocaine abusers: How low can we go, and with whom?. Addiction 2004, 99:349-360.
31. Petry N.M., Tedford J., Martin B. Reinforcing compliance with non-drug-related activities. Journal of Substance Abuse Treatment 2001, 20:33-44.
32. Prendergast M., Podus D., Finney J., Greenwell L. Contingency management for treatment of substance use disorders: A meta-analysis. Addiction 2006, 101:1546-1560.
33. Prigerson H.G., Desai R.A., Rosenheck R.A. Older adult patients with both psychiatric and substance abuse disorders: Prevalence and health service use. Psychiatric Quarterly 2001, 72:1-18.
34. Rajaratnam R., Sivesind D., Todman M., Roane D., Seewald R. The aging methadone maintenance patient: Treatment adjustment, long-term success, and quality of life. Journal of Opioid Management 2009, 5:27-37.
35. Reiger D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Co-morbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association 1990, 264:2511-2518.
36. Rice C., Longabaugh R., Beattie M., Noel N. Age group differences in response to treatment for problematic alcohol use. Addiction 1993, 88:1369-1375.
37. Rounsaville B.J., Petry N.M., Carroll K.M. Single versus multiple drug focus in substance abuse clinical trials research. Drug and Alcohol Dependence 2003, 70:117-125.
38. Satre D.D., Mertens J., Areán P.A., Weisner C. Contrasting outcomes of older versus middle-aged and younger adult chemical dependency patients in a managed care program. Journal of Studies on Alcohol 2003, 64:520-530.
39. Satre D.D., Mertens J.R., Areán P.A., Weisner C. Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program. Addiction 2004, 99:1286-1297.
40. Schonfeld L., Dupree L.W. Treatment approaches for older problem drinkers. International Journal of the Addictions 1995, 30:1819-1842.
41. Siegal H.A., Falck R.S., Wang J., Carlson R.G. Predictors of drug abuse treatment entry among crack-cocaine smokers. Drug and Alcohol Dependence 2002, 68:159-166.
42. Stout R.L., Wirtz P.W., Carbonari J.P., Del Boca F.K. Ensuring balanced distribution of prognostic factors in treatment outcome research. Journal of Studies on Alcohol 1994, (Suppl. 12):70-77.
43. 2008 National Household Survey on Drug Abuse 2010, Substance Abuse and Mental Health Services Administration, National Clearinghouse for Alcohol and Drug Information, Rockville, MD.
44. Vupputuri S., Batuman V., Muntner P., Bazzano L.A., Lefante J.J., Whelton P.K., He J. The risk for mild kidney function decline associated with illicit drug use among hypertensive men. American Journal of Kidney Diseases 2004, 43:629-635.
45. Warner E.A., Greene G.S., Buchsbaum M.S., Cooper D.S., Robinson B.E. Diabetic ketoacidosis associated with cocaine use. Archives of Internal Medicine 1998, 158:1799-1802.